In the original article, there was an error. The statement that mitochondrial ROS inhibit the activity of NEMO is wrong. Mitochondrial ROS are crucial for the activation of the IKK-NEMO complex.
A correction has been made to the section The Role Played by Mitochondria in the FcϵRI-Dependent Mast Cell Activation, subsection Mitochondrial ROS, paragraph 6. The correct paragraph appears below.
Mitochondrial ROS can stimulate NF-κB signaling by activating the kinase (IKK) of the inhibitor of NF-κB (IκB), which promotes its proteasome degradation and induces nuclear translocation of NF-κB (81, 84). Mitochondrial ROS-dependent activation of IKK can be mediated by several mechanisms, including the formation of intermolecular disulfide bonds in NF-κB essential modulator (NEMO), a component of the IKK complex (85).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
References
81
ParkJMinJ-SKimBChaeU-BYunJWChoiM-Set al. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neurosci Lett. (2015) 584:191–196. doi: 10.1016/j.neulet.2014.10.016
84
ZinovkinRARomaschenkoVPGalkinIIZakharovaVVPletjushkinaOYChernyakBVet al. Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. Aging. (2014) 6:661–74. doi: 10.18632/aging.100685
85
HerbMGluschkoAWiegmannKFaridAWolfAUtermöhlenOet al. Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO. Sci Signal. (2019) 12:eaar5926. doi: 10.1126/scisignal.aar5926
Summary
Keywords
mast cell, mitochondria, FcϵRI-dependent activation, IgE, allergy
Citation
Chelombitko MA, Chernyak BV, Fedorov AV, Zinovkin RA, Razin E and Paruchuru LB (2020) Corrigendum: The Role Played by Mitochondria in FcϵRI-Dependent Mast Cell Activation. Front. Immunol. 11:620293. doi: 10.3389/fimmu.2020.620293
Received
22 October 2020
Accepted
10 November 2020
Published
11 December 2020
Volume
11 - 2020
Edited and reviewed by
Pedro Manoel Mendes Moraes Vieira, Campinas State University, Brazil
Updates
Copyright
© 2020 Chelombitko, Chernyak, Fedorov, Zinovkin, Razin and Paruchuru.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maria A. Chelombitko, chelombitko@mail.bio.msu.ru; Lakhsmi Bhargavi Paruchuru, bhargavi.lakshmi@mail.huji.ac.il
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.